A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy

被引:48
作者
Liu, Wei [1 ,2 ]
Zukotynski, Katherine [3 ,4 ]
Emmett, Louise [5 ,6 ]
Chung, Hans T. [7 ,8 ]
Chung, Peter [8 ,9 ]
Wolfson, Robert [10 ,11 ]
Rachinsky, Irina [2 ,12 ]
Kapoor, Anil [4 ,13 ]
Metser, Ur [11 ,14 ]
Loblaw, Andrew [7 ,8 ,15 ]
Morton, Gerard [7 ,8 ]
Sexton, Tracy [1 ,2 ]
Lock, Michael [1 ,2 ]
Helou, Joelle [8 ,9 ]
Berlin, Alejandro [8 ,9 ]
Boylan, Colm [4 ,16 ]
Archer, Susan [1 ,2 ]
Pond, Gregory R. [17 ]
Bauman, Glenn [1 ,2 ]
机构
[1] London Hlth Sci Ctr, Dept Oncol, Div Radiat Oncol, London, ON, Canada
[2] Western Univ, London, ON, Canada
[3] Hamilton Hlth Sci Ctr, Dept Radiol, Hamilton, ON, Canada
[4] McMaster Univ, Hamilton, ON, Canada
[5] St Vincents Hosp, Dept Nucl Med & Theranost, Sydney, NSW, Australia
[6] Univ New South Wales, Sydney, NSW, Australia
[7] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Dept Radiat Oncol, Toronto, ON, Canada
[8] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[9] Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
[10] Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Toronto, ON, Canada
[11] Univ Toronto, Toronto, ON, Canada
[12] London Hlth Sci Ctr, Div Nucl Med, London, ON, Canada
[13] Urol Canc Ctr Res & Innovat, Hamilton, ON, Canada
[14] Princess Margaret Canc Ctr, Dept Med Imaging, Toronto, ON, Canada
[15] Univ Toronto, Inst Hlth Care Policy & Evaluat, Toronto, ON, Canada
[16] St Josephs Healthcare, Dept Diagnost Imaging, Hamilton, ON, Canada
[17] McMaster Univ, Dept Oncol, Hamilton, ON, Canada
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 106卷 / 03期
关键词
INTENSITY FOCUSED ULTRASOUND; DOSE-RATE BRACHYTHERAPY; SALVAGE RADICAL PROSTATECTOMY; QUALITY-OF-LIFE; METASTASIS-DIRECTED THERAPY; RADIATION-THERAPY; FUNCTIONAL OUTCOMES; LOCAL RECURRENCE; PHASE-II; FAILURE;
D O I
10.1016/j.ijrobp.2019.11.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Radio-recurrent prostate cancer is typically detected by a rising prostate-specific antigen and may reflect local or distant disease. Positron emission tomography (PET) radiotracers targeting prostate-specific membrane antigen, such as 18F-DCFPyL have shown promise in restaging men with recurrent disease postprostatectomy but are less well characterized in the setting of radio-recurrent disease. Methods and Materials: A prospective, multi-institutional study was conducted to evaluate the effect of 18F-DCFPyL PET/computed tomography (CT) when added to diagnostic imaging (DI; CT abdomen and pelvis, bone scan, multiparametric magnetic resonance imaging pelvis) for men with radio-recurrent prostate cancer. All men were imaged with DI and subsequently underwent 18F-DCFPyL PET/CT with local and central reads. Tie break reads were performed as required. Management questionnaires were completed after DI and again after 18F-DCFPyL PET/CT. Discordance in patterns of disease detected with 18F-DCFPyL PET/CT versus DI and changes in management were characterized. Results: Seventy-nine men completed the study. Most men had T1 disease (62%) and Gleason score <7 (95%). Median prostate-specific antigen at diagnosis was 7.4 ng/mL and at relapse was 4.8 ng/mL. DI detected isolated intraprostatic recurrence in 38 out of 79 men (48%), regional nodal recurrence in 9 out of 79 (11%), distant disease in 12 out of 79 (15%), and no disease in 26 out of 79 (33%). 18F-DCFPyL PET/CT detected isolated intraprostatic recurrence in 38 out of 79 men (48%), regional nodal recurrence in 21 out of 79 (27%), distant disease in 24 out of 79 (30%), and no disease in 10 out of 79 (13%). DI identified 8 out of 79 (10%) patients to have oligometastatic disease, compared with 21 out of 79 (27%) with 18F-DCFPyL PET/CT. 18F-DCFPyL PET/CT changed proposed management in 34 out of 79 (43%) patients. Conclusions: 18F-DCFPyL PET/CT identified extraprostatic disease in twice as many men with radio-recurrent prostate cancer compared with DI and detected a site of recurrence in 87% of men compared with 67% with DI. Furthermore, 18F-DCFPyL PET/CT identified potentially actionable disease (prostate only recurrence or oligometastatic disease) in 75% of men and changed proposed management in 43% of men. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:546 / 555
页数:10
相关论文
共 65 条
[1]   Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy [J].
Abreu, Andre Luis de Castro ;
Bahn, Duke ;
Leslie, Scott ;
Shoji, Sunao ;
Silverman, Paul ;
Desai, Mihir M. ;
Gill, Inderbir S. ;
Ukimura, Osamu .
BJU INTERNATIONAL, 2013, 112 (03) :298-307
[2]   Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study [J].
Baco, Eduard ;
Gelet, Albert ;
Crouzet, Sebastien ;
Rud, Erik ;
Rouviere, Olivier ;
Tonoli-Catez, Helene ;
Berge, Viktor ;
Chapelon, Jean-Yves ;
Eggesbo, Heidi B. .
BJU INTERNATIONAL, 2014, 114 (04) :532-540
[3]   Temporal Trends and Predictors of Salvage Cancer Treatment After Failure Following Radical Prostatectomy or Radiation Therapy An Analysis From the CaPSURE Registry [J].
Cary, K. Clint ;
Paciorek, Alan ;
Fuldeore, Mahesh J. ;
Carroll, Peter R. ;
Cooperberg, Matthew R. .
CANCER, 2014, 120 (04) :507-512
[4]   Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer [J].
Catton, Charles N. ;
Lukka, Himu ;
Gu, Chu-Shu ;
Martin, Jarad M. ;
Supiot, Stephane ;
Chung, Peter W. M. ;
Bauman, Glenn S. ;
Bahary, Jean-Paul ;
Ahmed, Shahida ;
Cheung, Patrick ;
Tai, Keen Hun ;
Wu, Jackson S. ;
Parliament, Matthew B. ;
Tsakiridis, Theodoros ;
Corbett, Tom B. ;
Tang, Colin ;
Dayes, Ian S. ;
Warde, Padraig ;
Craig, Tim K. ;
Julian, Jim A. ;
Levine, Mark N. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (17) :1884-+
[5]   Cancer Control and Functional Outcomes of Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Systematic Review of the Literature [J].
Chade, Daher C. ;
Eastham, James ;
Graefen, Markus ;
Hu, Jim C. ;
Karnes, R. Jeffrey ;
Klotz, Laurence ;
Montorsi, Francesco ;
van Poppel, Hendrik ;
Scardino, Peter T. ;
Shariat, Shahrokh F. .
EUROPEAN UROLOGY, 2012, 61 (05) :961-971
[6]   A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526) [J].
Crook, Juanita M. ;
Zhang, Peixin ;
Pisansky, Thomas M. ;
Trabulsi, Edouard J. ;
Amin, Mahul B. ;
Bice, William ;
Morton, Gerard ;
Pervez, Nadeem ;
Vigneault, Eric ;
Catton, Charles ;
Michalski, Jeff ;
Roach, Mack, III ;
Beyer, David ;
Jani, Ashesh ;
Horwitz, Eric ;
Donavanik, Viroon ;
Sandler, Howard .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (02) :335-343
[7]   Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy [J].
Crook, Juanita M. ;
O'Callaghan, Christopher J. ;
Duncan, Graeme ;
Dearnaley, David P. ;
Higano, Celestia S. ;
Horwitz, Eric M. ;
Frymire, Eliot ;
Malone, Shawn ;
Chin, Joseph ;
Nabid, Abdenour ;
Warde, Padraig ;
Corbett, Thomas ;
Angyalfi, Steve ;
Goldenberg, S. Larry ;
Gospodarowicz, Mary K. ;
Saad, Fred ;
Logue, John P. ;
Hall, Emma ;
Schellhammer, Paul F. ;
Ding, Keyue ;
Klotz, Laurence .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (10) :895-903
[8]   Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients [J].
Crouzet, Sebastien ;
Blana, Andreas ;
Murat, Francois J. ;
Pasticier, Gilles ;
Brown, Stephen C. W. ;
Conti, Giario N. ;
Ganzer, Roman ;
Chapet, Olivier ;
Gelet, Albert ;
Chaussy, Christian G. ;
Robertson, Cary N. ;
Thuroff, Stefan ;
Ward, John F. .
BJU INTERNATIONAL, 2017, 119 (06) :896-904
[9]   A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer [J].
De Visschere, Pieter J. L. ;
Standaert, Chloe ;
Futterer, Jurgen J. ;
Villeirs, Geert M. ;
Panebianco, Valeria ;
Walz, Jochen ;
Maurer, Tobias ;
Hadaschik, Boris A. ;
Lecouvet, Frederic E. ;
Giannarini, Gianluca ;
Fanti, Stefano .
EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (01) :47-76
[10]   Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial [J].
Dearnaley, David ;
Syndikus, Isabel ;
Mossop, Helen ;
Khoo, Vincent ;
Birtle, Alison ;
Bloomfield, David ;
Graham, John ;
Kirkbride, Peter ;
Logue, John ;
Malik, Zafar ;
Money-Kyrle, Julian ;
O'Sullivan, Joe M. ;
Panades, Miguel ;
Parker, Chris ;
Patterson, Helen ;
Scrase, Christopher ;
Staffurth, John ;
Stockdale, Andrew ;
Tremlett, Jean ;
Bidmead, Margaret ;
Mayles, Helen ;
Naismith, Olivia ;
South, Chris ;
Gao, Annie ;
Cruickshank, Clare ;
Hassan, Shama ;
Pugh, Julia ;
Griffin, Clare ;
Hall, Emma .
LANCET ONCOLOGY, 2016, 17 (08) :1047-1060